G9610 – Documentation of medical reason(s) in the patient's record for not ordering anti-platelet agents

Long description

Documentation of medical reason(s) in the patient's record for not ordering anti-platelet agents

Short description

Doc md rsn no antipla

Pricing indicator

00 Not separately priced by Part B (bundled, not covered or Part A only)

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

Z2 Undefined codes

Added

January 1, 2016

Last change

January 1, 2017 – No change

Nearby G codes

• G9602 – Patient not discharged to home by post-operative day #7
• G9603 – Patient survey score improved from baseline following treatment
• G9604 – Patient survey results not available
• G9605 – Patient survey score did not improve from baseline following treatment
• G9606 – Intraoperative cystoscopy performed to evaluate for lower tract injury
• G9607 – Documented medical reasons for not performing intraoperative cystoscopy (e.g., urethral pathology precluding cystoscopy, any patient who has a congenital or acquired absence of the urethra) or in the case of patient death
• G9608 – Intraoperative cystoscopy not performed to evaluate for lower tract injury
• G9609 – Documentation of an order for anti-platelet agents
• G9611 – Order for anti-platelet agents was not documented in the patient's record, reason not given
• G9612 – Photodocumentation of two or more cecal landmarks to establish a complete examination
• G9613 – Documentation of post-surgical anatomy (e.g., right hemicolectomy, ileocecal resection, etc.)
• G9614 – Photodocumentation of less than two cecal landmarks (i.e., no cecal landmarks or only one cecal landmark) to establish a complete examination
• G9615 – Preoperative assessment documented
• G9616 – Documentation of reason(s) for not documenting a preoperative assessment (e.g., patient with a gynecologic or other pelvic malignancy noted at the time of surgery)
• G9617 – Preoperative assessment not documented, reason not given
• G9618 – Documentation of screening for uterine malignancy or those that had an ultrasound and/or endometrial sampling of any kind